# Epoch Biodesign: Biotechnology, London, United Kingdom

> Epoch Biodesign: Epoch Biodesign is a London-based synthetic biology company founded in 2019. Based in London, United Kingdom. Founded 2019.

Source: https://millionrounds.com/startup/epoch-biodesign (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Biotechnology startup](https://millionrounds.com/companies)

# Epoch Biodesign

Epoch Biodesign is a London-based synthetic biology company founded in 2019.

Funding reported Last round: Undisclosed round

Biotechnology London, United Kingdom

Company summary

- **Founded:** 2019 7 years old
- **Team:** 81 51 to 200 people
- **Funding reported:** 16M as listed, currency not stated
- **Last round:** Undisclosed round Jan 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Epoch Biodesign has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Epoch Biodesign

Epoch Biodesign is a London-based synthetic biology company founded in 2019.

The company focuses on using AI-designed enzymes to facilitate infinite, virgin-quality recycling of mixed plastics and blended textiles, starting with nylon 6,6. Their mission is to address climate challenges by breaking down complex waste into high-purity chemical building blocks, promoting a circular economy for difficult-to-recycle materials. The company employs a proprietary enzymatic biorecycling process that deconstructs plastic waste at the molecular level, producing recycled nylon 6,6 that matches the quality of virgin plastic. Epoch Biodesign serves B2B clients across various industries, including apparel, automotive, and packaging, providing sustainable materials and low-carbon chemical building blocks. With a team of around 32 scientists and engineers, the company is building a multi-tonne demo facility aimed at scaling production to 150 metric tonnes annually by 2026.

## What company datasets say Epoch Biodesign raised

Funding, as reported

Reported in all **16M** in the source's currency

Rounds **9**

Last round **Undisclosed round**

Last round size **12M**

Last round date **Jan 2024**

Investors listed **10**

## Funding filed with regulators

Epoch Biodesign filed 5 raises, $29M in all. Filings say how much was sold and to how many investors; they never name the investors.

- Mar 2025 **$1.1M** UK share allotment
- Jan 2025 **$1.4M** UK share allotment
- Dec 2024 **$2.4M** UK share allotment
- Nov 2024 **$13M** UK share allotment
- Dec 2021 **$11M** UK share allotment

## On 5 portfolio pages

Investors who name them

- [Avonmore Developments](https://millionrounds.com/fund/avonmore-developments)
- [The Venture Collective](https://millionrounds.com/fund/the-venture-collective)
- [Cambridge Angels](https://millionrounds.com/fund/cambridge-angels)
- [regeneration.vc](https://millionrounds.com/fund/regeneration-vc)
- [Kibo Invest](https://millionrounds.com/fund/kibo-invest)

Each firm lists Epoch Biodesign on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

nylon recycling polyester recycling chemical depolymerization low-temperature processes biotech for waste management consumer goods & retail manufacturing sustainable materials materials science waste transformation climate solutions molecular recycling fossil carbon displacement waste management ai and synthetic biology plastic waste

Built with from their website

Docker Amazon CloudFront WordPress.org Salesforce CRM Analytics Google Workspace CloudFlare Viewport Meta LinkedIn Ads Echo Webflow Hosting

+8 more

AI Google Meet Act! CloudFlare CDN Mist Mobile Friendly Open Graph jQuery

- **Sector:** Biotechnology
- **Industry code:** NAICS 32519, 541714, 325220, SIC 2899, 8731, 2824
- **Region:** England
- **Revenue:** 1.2M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/epoch-biodesign)

## Biotechnology in United Kingdom

Startups like it

- [**CellCentric** Saffron Walden · founded 2004 *Raised*](https://millionrounds.com/company/cellcentric)
- [**Oxford BioTherapeutics** Oxford · founded 2004 *Raised*](https://millionrounds.com/company/oxford-biotherapeutics)
- [**Chroma Therapeutics** Milton · founded 2020](https://millionrounds.com/startup/chroma-therapeutics)
- [**Oxagen** Abingdon · founded 1996](https://millionrounds.com/startup/oxagen)
- [**RQ Biotechnology Ltd.** London · founded 2022](https://millionrounds.com/startup/rq-biotechnology-ltd)
- [**ONI** Oxford · founded 2016](https://millionrounds.com/startup/oni-2)
- [**Oxular** Oxford · founded 2014](https://millionrounds.com/startup/oxular)
- [**Maxion Therapeutics** Cambridge · founded 2020](https://millionrounds.com/startup/maxion-therapeutics)

## Is this your company?

Add your raise, your deck and your story, and put Epoch Biodesign in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)